InMed Pharmaceuticals Inc. INM has released its financial results for the third quarter of fiscal 2023 ended March 31, 2023 and is insightful sales of
InMed Pharmaceuticals Inc. (NASDAQ:INM) released insightful financial results for the second quarter of fiscal 2023 ended December 31, 2022 Revenue of $469,783, an increase of
VANCOUVER, British Columbia, December 12, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “company“) INM, a leader in the pharmaceutical research, development and
U.S. roads have become increasingly dangerous for pedestrians, with a new analysis from Bader Law revealing a 48% increase in pedestrian fatalities since 2014. The
Losing weight can be an uphill battle for many adults, especially when traditional methods such as diet modification and increased physical activity yield slow or
In the digital world, the boundaries of ownership have become increasingly blurred. The speed at which information travels and the ease with which it can
injuredly News Provide the latest news. All News World News, Business News, Health Care, Life Style. All News Around the World Update On This Website.